AU2001287111A1 - Human vomeronasal receptor-3 - Google Patents
Human vomeronasal receptor-3Info
- Publication number
- AU2001287111A1 AU2001287111A1 AU2001287111A AU8711101A AU2001287111A1 AU 2001287111 A1 AU2001287111 A1 AU 2001287111A1 AU 2001287111 A AU2001287111 A AU 2001287111A AU 8711101 A AU8711101 A AU 8711101A AU 2001287111 A1 AU2001287111 A1 AU 2001287111A1
- Authority
- AU
- Australia
- Prior art keywords
- human vomeronasal
- vomeronasal receptor
- receptor
- human
- vomeronasal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Toxicology (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Cell Biology (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US23097700P | 2000-09-07 | 2000-09-07 | |
US60/230,977 | 2000-09-07 | ||
PCT/US2001/027670 WO2002020612A2 (en) | 2000-09-07 | 2001-09-06 | Human vomeronasal receptor-3 |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001287111A1 true AU2001287111A1 (en) | 2002-03-22 |
Family
ID=22867316
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001287111A Abandoned AU2001287111A1 (en) | 2000-09-07 | 2001-09-06 | Human vomeronasal receptor-3 |
Country Status (3)
Country | Link |
---|---|
US (1) | US20020146766A1 (en) |
AU (1) | AU2001287111A1 (en) |
WO (1) | WO2002020612A2 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2003288676A1 (en) * | 2002-11-15 | 2004-06-15 | Universite De Geneve | Identification of an agonist-v1r receptor pair functional in the olfactory system and uses thereof |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0858505B1 (en) * | 1995-10-19 | 2004-12-29 | The Trustees Of Columbia University In The City Of New York | Cloning of vertebrate pheromone receptors and uses thereof |
EP0996635A4 (en) * | 1997-06-30 | 2003-08-27 | Harvard College | Novel family of pheromone receptors |
CN1331098A (en) * | 2000-06-28 | 2002-01-16 | 上海博德基因开发有限公司 | Polypeptide-information receptor protein VN1-18 and polynucleotide for coding it |
-
2001
- 2001-09-06 AU AU2001287111A patent/AU2001287111A1/en not_active Abandoned
- 2001-09-06 US US09/947,744 patent/US20020146766A1/en not_active Abandoned
- 2001-09-06 WO PCT/US2001/027670 patent/WO2002020612A2/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
US20020146766A1 (en) | 2002-10-10 |
WO2002020612A2 (en) | 2002-03-14 |
WO2002020612A3 (en) | 2003-01-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB2359254B (en) | Formulation | |
AU2001252135A1 (en) | Therapeutic agents | |
AU2001260327A1 (en) | Chair | |
AU2001279540A1 (en) | Dental splint | |
AU2001274548A1 (en) | Syringe | |
AU2001263839A1 (en) | Liquid formulations | |
AU4439701A (en) | Patient support | |
AU2001259702A1 (en) | Tissue regrafting | |
GB0000891D0 (en) | Formulation | |
AU2001233208A1 (en) | Human sulfatases | |
AU2001290239A1 (en) | Medicinal composition | |
AU2001272974A1 (en) | Human receptors | |
AU2002227925A1 (en) | Human beta-defensin-3 | |
AU2001270129A1 (en) | Human phosphodiesterases | |
AU2001232244A1 (en) | Drug comprising combination | |
GB0009612D0 (en) | Therapeutic formulations | |
AU2001273903A1 (en) | Therapeutic agents | |
AU2001247841A1 (en) | Medical procedure | |
AU2001260236A1 (en) | Restricted use syringe | |
AU2001252200A1 (en) | Chair | |
AU2001275696A1 (en) | Therapeutic agent | |
AUPR099200A0 (en) | New formulation | |
AU2001287111A1 (en) | Human vomeronasal receptor-3 | |
AU2002215030A1 (en) | Chair | |
AU2002230568A1 (en) | Human v2 vomeronasal receptor |